ApiJect

ApiJect is a private medical device company developing a novel drug delivery platform centered on a prefilled injector made via Blow-Fill-Seal (BFS) technology. By integrating a BFS container with a needle hub, the company offers a solution designed to be cost-competitive with traditional vial-and-syringe formats while offering advantages in supply chain simplicity, durability, and environmental impact. Founded in 2018, ApiJect operates as a technology and development partner for pharmaceutical companies, with a new manufacturing facility planned for Apex, North Carolina, in 2026. The company's mission is to expand global access to safe injections across diverse markets.

Prefilled injector platform combining an aseptically-filled Blow-Fill-Seal (BFS) plastic container with a proprietary pen needle hub. Designed for single-dose delivery of liquid medicines and vaccines.

ApiJect competes with traditional glass vial and syringe suppliers (e.g., Schott, Gerresheimer, BD) and makers of conventional prefilled syringes. Its primary differentiation is cost, supply chain simplicity, and scalability via BFS technology, positioning it as a disruptor rather than a direct like-for-like competitor.